🕵️ Medifast Inc ($MED)
SEC insider & ownership activity, last 12 months · CIK 910329 · every row links its SEC filing
Over the last 12 months insiders bought $242K with no open-market selling against it. Daniel R. Chard bought $179K in discretionary trades (Mar). Charles Schwab Investment Management Inc trimmed 7.1% → 5.7%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $242K (3 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Daniel R. Chard | 1 | $179K | 0 | – | Mar 20, 2026 |
| Schlackman Scott | 2 | $63K | 0 | – | May 11, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 7.0% | 13G | May 14, 2026 | filing ↗ | |
| Renaissance Technologies Holdings Corporation | 7.0% | 13G | May 14, 2026 | filing ↗ | |
| Citadel Securities GP LLC | 6.5% | 13G | May 15, 2026 | filing ↗ | |
| Citadel Securities LLC | 6.5% | 13G | May 15, 2026 | filing ↗ | |
| Citadel Securities Group LP | 6.5% | 13G | May 15, 2026 | filing ↗ | |
| Kenneth Griffin | 6.5% | 13G | May 15, 2026 | filing ↗ | |
| Parsa Kiai | 6.0% | 13D | Mar 13, 2026 | filing ↗ | |
| Steamboat Capital Partners, LLC | 6.0% | 13D | Mar 13, 2026 | filing ↗ | |
| Charles Schwab Investment Management Inc | 5.7% | 13G | May 14, 2026 | filing ↗ | |
| Blackrock, Inc. | exited | 13G | Jul 29, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jul 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 29, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 19, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 19, 2026 | filing ↗ |
| Earnings (2.02) | May 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 4, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 19, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 19, 2026 | filing ↗ |
| Earnings (2.02) | Feb 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 30, 2025 | filing ↗ |
| Earnings (2.02) | Nov 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 3, 2025 | filing ↗ |
| Earnings (2.02) | Aug 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 4, 2025 | filing ↗ |